Living

Can Gut Health Flag Parkinson’s Disease Risk Decades Before Symptoms Appear? Breaking Down the Study

Can Gut Health Flag Parkinson’s Risk Before Symptoms Appear
The silhouettes of women dancing are seen in the old town of Willemstad, Curacao, in the Dutch Caribbean. AFP via Getty Images

If you have a parent, sibling or grandparent with Parkinson’s, a new line of research may interest you: scientists are finding that gut health patterns could help identify who’s at risk for the disease years — possibly decades — before the first tremor appears.

A new observational study from University College London suggests that distinct shifts in gut bacteria may serve as an early biological signal of Parkinson’s vulnerability. The findings build on a growing body of microbiome research and point toward a future where a stool sample, combined with genetic information, might help flag risk long before clinical symptoms emerge.

How the Study Was Designed

UCL researchers analyzed stool samples from three groups in the United Kingdom:

  • 271 people already diagnosed with Parkinson’s disease
  • 43 asymptomatic individuals carrying the GBA1 genetic variant
  • 150 healthy controls without the GBA1 variant or a Parkinson’s diagnosis

Comparing these three groups allowed the team to look for microbial signatures that distinguish not only people with active disease, but also those at elevated genetic risk who haven’t yet developed symptoms.

Researchers found that people who already have Parkinson’s disease had noticeable differences in their gut bacteria compared to healthy people. More than a quarter of the gut microbes showed different levels or balances. This suggests the gut microbiome is strongly linked to the disease.

Why the GBA1 Group Matters for Parkinson’s Research

For readers tracking inherited risk, the GBA1 carriers are the most compelling part of this study. The mutation is strongly associated with Parkinson’s disease and is estimated to increase risk by nearly 30 times. Because these participants were still asymptomatic, their microbiome profiles offer a rare window into what may be happening biologically before diagnosis.

Building on a Decade of Microbiome Research

This isn’t the first study to draw a line between gut bacteria and Parkinson’s disease. An influential 2015 paper was among the first to demonstrate that people with the disease have a distinctly different gut microbiome than healthy individuals.

In that earlier work, researchers analyzed fecal samples from Parkinson’s patients and matched controls. They found consistent differences in microbial composition, including reduced levels of bacteria that produce short-chain fatty acids — molecules important for maintaining the gut lining and regulating inflammation. Bacterial groups associated with inflammatory activity, meanwhile, were found in higher relative abundance among patients.

The authors proposed that these shifts could be biologically meaningful, potentially affecting immune signaling, gut barrier function and inflammatory pathways implicated in Parkinson’s. They cautioned that the findings were correlational — meaning the study couldn’t determine whether microbiome changes contribute to the disease or arise from it.

The Gut Connection in Plain Terms

The Parkinson’s Foundation notes that “about 80% of people with Parkinson’s experience gastrointestinal (GI) issues. These issues can develop up to 10-20 years before a PD diagnosis. Therefore, the gut microbiome is a ripe target for future treatments that could potentially stop or slow PD progression at an early stage.”

That 10-to-20-year window is what makes microbiome research so attractive to researchers — and so relevant to people with a known family risk.

The Foundation also offers practical guidance: “However, the gut microbiome is very complex and unique to each person. If you are suffering from gastrointestinal issues, try eating more fiber-rich foods and less starchy ones, drinking more fluids and increasing exercise. Speak to your doctor before trying pro- or pre-biotic supplements that alter your gut microbiome, since they may affect people differently.”

For now, microbiome testing isn’t a clinical screening tool for Parkinson’s. But the science is moving in a direction that midlife adults watching their family history will want to follow.

This article was created by content specialists using various tools, including AI.

Samantha Agate
Belleville News-Democrat
Samantha Agate is a content specialist working with McClatchy Media’s Trend Hunter and national content specialists team.
Get unlimited digital access
#ReadLocal

Try 1 month for $1

CLAIM OFFER